血 Apolipoprotein A-I 是发生败血症的因果保护因素
Kyle R Campbell1, Kantimas Sitthikool1, Kelly Roveran Genga1
1Centre for Heart Lung Innovation, St. Paul's Hospital, The University of British Columbia, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
脂蛋白AI (ApoAI) 显著地防止了败血症发病率和死亡率. 这一发现表明ApoAI可能是一个治疗目标,可能通过降低脂多糖 (LPS) 水平.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 心血管生物学 心血管生物学
- 传染性疾病 传染性疾病
背景情况:
- 阿波脂蛋白AI (ApoAI) 是高密度脂蛋白 (HDL) 的关键组成部分,在结合病原体脂质和调节炎症方面发挥作用.
- 败血症是一种危及生命的疾病,其特点是宿主对感染的反应失调,通常涉及炎症和器官功能障碍.
研究的目的:
- 调查Apolipoprotein AI (ApoAI) 在败血症发病率和死亡率中的因果作用.
- 探索ApoAI在败血症中发挥保护作用的潜在机制,特别是其对循环脂多糖 (LPS) 水平的影响.
主要方法:
- 从英国生物银行 (UKB) 队列中对442,601名欧洲患者进行了回顾性分析,重点关注11,643名败血症患者.
- 孟德尔随机化 (MR) 分析使用ApoAI遗传分数作为评估因果关系的仪器变量.
- 在跨祖先性败血症队列 (VASST和奇巴) 中进行敏感性分析和验证,以确认发现并评估其与其他脂质参数的独立性.
主要成果:
- 与没有发生败血症的人相比,在患有败血症的人群中观察到较低的基线ApoAI水平 (P < 0.0001).
- 核磁共振分析表明,ApoAI在UKB队列中对败血症发病率 (OR=0.87) 和28天死亡率 (OR=0.73) 有因果保护作用.
- 在欧洲 (VASST) 和东亚 (Chiba) 队列中验证了ApoAI对败血症死亡率的保护作用,具有重叠的置信区间.
- 发现ApoAI可因果性地降低循环LPS水平 (logOR=-0.23),这表明其保护作用的潜在机制.
结论:
- 血ApoAI水平为对败血症病理生物学提供了显著的因果保护.
- 在败血症中ApoAI的保护作用可能至少部分通过其降低循环LPS水平的能力来调解.
- 这些发现突出了ApoAI作为毒症管理的潜在治疗点.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
05:28Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
相关概念视频
Atherosclerosis I: Introduction
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Acute Kidney Injury II: Pathophysiology
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
